Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin-sparing versus insulin-based acute glucose lowering in type 2 diabetes
2012-001208-39Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Apr 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of liraglutide and insulin detemir in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Changes in myocardial lipid content. Started Apr 2012; status: completed.
02
Drugs
liraglutideinsulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2012-001208-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001208-39.